Curative Biotechnology, Inc.
CUBT
$0.0118
$0.00032.61%
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Net Income | 44.02% | 41.94% | -- | -- | -- |
| Total Depreciation and Amortization | -72.13% | -58.54% | -- | -- | -- |
| Total Amortization of Deferred Charges | 946.77% | 431.23% | -- | -- | -- |
| Total Other Non-Cash Items | -92.63% | -88.77% | -- | -- | -- |
| Change in Net Operating Assets | 633.96% | 722.76% | -- | -- | -- |
| Cash from Operations | -91.20% | -226.93% | -- | -- | -- |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -57.79% | -9.11% | -- | -- | -- |
| Cash from Investing | -71.72% | -25.00% | -- | -- | -- |
| Total Debt Issued | 152.91% | 147.82% | -- | -- | -- |
| Total Debt Repaid | 11.62% | 46.99% | -- | -- | -- |
| Issuance of Common Stock | -64.65% | -13.51% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -17.63% | 27.71% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -201.44% | -183.85% | -- | -- | -- |
